← Open Payments lookup

CLAUDE SMITH: Open Payments

NPI 1619929676 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,190 in 19 payments from 12 companies in 2025. Trend: 2023 $588 · 2024 $727 · 2025 $4,190

Debt forgiveness: $3,602Food & beverage: $588
CompanyPaymentsAmount
Neuronetics, Inc.1$3,602
Teva Pharmaceuticals USA, Inc.6$211
Supernus Pharmaceuticals, Inc.1$119
Janssen Pharmaceuticals, Inc3$98
ABBVIE INC.1$28
Alkermes, Inc.1$25
Otsuka America Pharmaceutical, Inc.1$24
Almatica Pharma LLC1$20
Lundbeck LLC1$19
E.R. Squibb & Sons, L.L.C.1$16

Products named: NEUROSTAR TMS THERAPY SYSTEM, UZEDY, Qelbree, INVEGA SUSTENNA, VRAYLAR, LYBALVI, ABILIFY ASIMTUFII, LOREEV XR.

Industry payments across MD — which companies pay providers there.